Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Research

Düşünen Adam. 2013; 26(1): 22-27

Liver enzymes and bilirubin levels during atomoxetine treatment in children and adolescents

Özden Şükran Üneri, Mazlum Çopur, Canan Tanıdır,Hatice Güneş, Ayten Erdoğan.

Objective: Atomoxetine is the first non stimulant medication approved by FDA for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The objective of this study was to investigate the changes in the liver enzymes levels associated with one month atomoxetine treatment in children with ADHD.

Method: A retrospective chart review was done to evaluate patients treated with only atomoxetine in Bakırköy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatry and Neurological Disease, Child and Adolescent Psychiatry Clinic outpatient unit between September 2010 and December 2010. A total of 62 patients between 6-15 years of age were eligible for the study. Patients’ baseline and one month follow-up hepatobiliary function tests including alanine aminotransferase (ALT) and aspartat aminotransferase (AST), gamma glutamyl transferase (GGT), alkaline phosphatase (ALP) and total serum bilirubin levels were noted.

Results: No case of jaundice or hepatic failure was seen during the one month treatment period. ALT levels in the first month were significantly lower than baseline. The mean levels of other liver enzymes and bilirubin levels of the patients at the first month were not significantly different than baseline. Clinically nonsignificant elevation of liver enzymes and bilirubin from the defined normal levels were observed in 8 (12.9%) patients.

Conclusion: Taking into account the limitations of a retrospective chart review in nonrandomized samples, it appears that atomoxetine treatment in short term does not lead to abnormal liver function changes at therapeutic doses in children and adolescents. Prospective studies are needed to assess liver function tests abnormalities in youth population using atomoxetine.

Key words: Atomoxetine, ADHD, liver enzymes, hepatotoxicity

Article Language: Turkish English

Full-text options

Full-text Article

Journal of Environmental and Occupational Science


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.